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A B S T R A C T
Background
Coronary artery bypass surgery (CABG) may be life saving, but known side effects include neurological damage and cognitive impair-
ment. The temperature used during cardiopulmonary bypass (CPB) may be important with regard to these adverse outcomes, where
hypothermia is used as a means of neuroprotection.
Objectives
To assess the effectiveness of hypothermia during CABG in reducing neurological damage and subsequent cognitive deficits.
Search methods
The Cochrane Controlled Trials Register was searched for randomised controlled trials (RCT) and this was updated by searching
MEDLINE and EMBASE to December 1999 using database specific RCT filters. Reference lists of retrieved articles were searched and
experts in the field were contacted.
Selection criteria
Only RCTs were considered. All patients undergoing CABG, either first time or revisions, elective or emergency procedures, were
included. Any hypothermia protocol was considered. Only trials reporting neurological outcomes were included.
Data collection and analysis
Studies were selected independently and data were extracted from the source papers independently by two reviewers. Authors were
contacted for further information. Studies were combined with meta-analysis where appropriate, and meta-regression was used to
explore heterogeneity.
Main results
There was a trend towards a reduction in the incidence of non fatal strokes in the hypothermic group (OR0.68 (0.43, 1.05)). Conversely,
there was a trend for the number of non stroke related perioperative deaths to be higher in the hypothermic group (OR 1.46 (0.9,
2.37)). There was no evidence to suggest that hypothermia had an effect on the incidence of non fatal myocardial infarction (OR 1.05
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(0.81, 1.37)), but the incidence of another marker of myocardial damage, low output syndrome, was higher in the hypothermic group
(OR 1.21 (0.99, 1.48). When pooling all “bad” outcomes (stroke, perioperative death, myocardial infarction, low output syndrome,
intra aortic balloon pump use) there was no significant advantage of either hypothermia or normothermia (OR 1.07 (0.92, 1.24)).
Only 4 of 17 trials reported neuropsychological function as an outcome.
Authors’ conclusions
This review could find no definite advantage of hypothermia over normothermia in the incidence of clinical events. Hypothermia was
associated with a reduced stroke rate, but this is off set by a trend towards an increase in non stroke related perioperative mortality
and myocardial damage. There is insufficient data to date to draw any conclusions about the use of mild hypothermia. Similarly, there
is insufficient data to date to comment on the effect of temperature during CPB on subtle neurological deficits, and further trials are
needed in these areas.
P L A I N L A N G U A G E S U M M A R Y
There is not enough evidence to show that lowering body temperature can reduce nerve damage during coronary artery bypass
surgery.
For people with severe coronary artery (heart) disease, bypass surgery can be life saving. However, bypass surgery is sometimes associated
with neurological complications, where very occasionally patients may suffer a stroke, or more commonly memory or personality may
be affected. The temperature used during bypass surgery may influence these adverse effects. Reducing the temperature during surgery
(hypothermia) may protect the brain and reduce the risk of complications. The review of trials found that there was not enough evidence
to show the protective effects of hypothermia. More research is needed.
B A C K G R O U N D
Coronary artery by-pass surgery or grafting (CABG) may be life-
saving in patients with severe coronary artery disease, but may
also result in neurological damage and cognitive impairment. Al-
though the incidence of gross neurological events followingCABG
is fairly low, with the incidence of stroke between 0.5-2% (Javid
1969,Gilman 1990), more subtle neuropsychological impairment
after CABG has been reported in between 15-80% patients and
as high as 100% in the elderly (Hammeke 1988). Whilst survival
is of obvious value, neurological damage and subsequent cogni-
tive impairment may have devastating consequences on patients’
emotional, occupational and social life. Relatively little attention
has been paid to these sequelae, and the British Cardiac Patients
Association have indicated that a review in this area is a priority.
Early reports suggested that clinical brain damage following
CABG was relatively rare (Gersh 1983). Recently, more subtle
neurological deficits have been reported following CABG, where
measurable deficits are present in almost half of patients at one
week, with a third of patients showing deficits at 2 months post
surgery (Toner 1998). Most studies report an improvement in
cognitive deficits with increasing time post surgery, possibly due
to reversibility of injury, although the possibility of familiariza-
tion with the tests has been debated (Newman 1992, Robinson
1990). Although neurological deficits are often transient, affected
individuals are more likely to show signs of early dementia at 5
years post surgery (Sotaniemi 1986). Small cerebral ischemic le-
sions have been detected by magnetic resonance imaging (MRI)
following CABG, but the clinical significance of these is debated
(Vanninen 1998).
Neurological damage associated with CABG may occur through
a number of different mechanisms. First, many patients with
coronary artery disease may also have cerebrovascular disease and
CABG may trigger an acute cerebrovascular accident or stroke.
Second, themethod and duration ofmechanical by-passmay cause
micro-emboli to develop which may result in cerebral emboli,
insufficient cerebral blood flow, focal ischemia and neurological
damage sufficient to cause cognitive impairment. Third, cognitive
impairment may be due to depressive illness associated with coro-
nary artery disease, or following CABG. This review however is
not concerned with the psychiatric sequelae of CABG.
Specific interventions to reduce the risk of neurological damage
and cognitive impairment following CABG have been developed
and fall into 4 major groups:
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1) Degree of hypothermia and warming during CABG (Cook
1994; Craver 1995; Heyer 1997).
2) Mechanical interventions to reduce micro-emboli in by-pass
machines (Hessel 1980;Henze 1990; Sellman1991;Taggart 1997;
Toner 1997).
3) Anaesthetic and pharmacological strategies tomaintain cerebral
perfusion and neuroprotection (Fish 1987; Bashein 1990; Zaidan
1991; Gold 1995).
4) Maintenance of physiological homeostasis during surgery
through control of acid-base balance, substrate load and glucose
management (Griffin 1992; Engelhardt 1996; Patel 1996).
This review will focus on the degree of hypothermia and warming
during CABG on neurological outcome and cognitive function.
Normothermia during coronary bypass surgery has been shown
to be an important risk factor for stroke (Odds Ratio 4.85) (Rao
1995). Hypothermia may provide cerebral protection by reducing
cerebral oxygen consumption, and decreasing the risk of cerebral
ischaemia due to cerebral emboli as a result of lower cerebral blood
flow requirements.
Whilst we are primarily interested in the effects of systemic tem-
perature during cardiopulmonary bypass (CPB) on neurological
protection, the mode of delivery of cardioplegia to the heart dur-
ing surgery may also affect embolic load (Baker 1995). Several my-
ocardial protection strategies have been developed using cardiople-
gia of different temperatures, composition, and different modes of
delivery to the heart, either retrograde or antegrade, continuous or
intermittent.We will also examine markers of myocardial damage,
as there may be a trade off between myocardial protection and
neurological protection.
A previous review of neurological outcomes and cardiopulmonary
temperature has been conducted (Christakis 1995). The authors
could not find any advantage of hypothermia versus normoth-
ermia during CABG in terms of both the incidence of strokes
and deficits in neuropsychological function. However, this review
was not formally systematic in its coverage, included some non-
randomized studies, and several randomized controlled trials have
been published since this time. Consequently, an up to date sys-
tematic review is indicated.
O B J E C T I V E S
To assess the effectiveness of hypothermia during CABG in reduc-
ing neurological damage and subsequent cognitive deficits.
M E T H O D S
Criteria for considering studies for this review
Types of studies
Randomized controlled trials with parallel group design.
Types of participants
Adults of all ages (18 years plus) undergoing CABG for the first
time or revisions. This includes emergency and elective procedures.
Types of interventions
Hypothermia during CABG. Any hypothermia protocol has been
included. Protocols using mildly hypothermic or tepid temper-
atures have been analysed separately. Effects of the intervention
on outcome variables have been examined over the short term
(within one week of surgery) and longer term (up to 3 months
post surgery) to assess short and longer term effects of neurological
damage following CABG.
Types of outcome measures
Neurological outcomes:
Clinical evidence of cerebrovascular accident or stroke
Neuroradiological evidence of brain infarction
Neurological deficits identified by neurological examination
Neuropsychological testing for cognitive deficits
Trans-cranial Doppler estimates of micro-emboli
Biochemical markers for cerebral damage (e.g. S-100 protein, neu-
rospecific endolase)
Subjective complaints of behaviour or memory change from pa-
tient or family
Quality of life measures.
Other clinical outcomes:
Perioperative death not caused by stroke
Perioperative non fatal myocardial infarction
Low output syndrome (LOS) and intra-aortic balloon pump use
(IABP) as markers for myocardial damage
Search methods for identification of studies
The Cochrane Controlled Trials Register (CCTR) was searched
using the strategy outlined below. This was updated by searching
MEDLINE to December 1999 onOvid using a standard RCT fil-
ter (Dickersin 1994) and EMBASE 1998 toDecember 1999 using
an EMBASE RCT filter (Lefebvre 1996). In addition searches of
reference lists of papers were made and expert advice was sought.
1 CORONARY-ARTERY-BYPASS*:ME
2 (CORONARY and BYPASS)
3 (AORTOCORONARY and BYPASS)
4 (AORTOCORONARY and SHUNT)
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5 (AORTOCORONARY and ANASTOMOSIS)
6 (CORONARY and GRAFT)
7 (CORONARY and SURGERY)
8 (CARDIOPULMONARY and BYPASS)
9 EXTRACORPOREAL-CIRCULATION*:ME
10 EXTRACORPOREAL
11 HEART-ARREST-INDUCED*:ME
12 CARDIOPLEGI*
13 HYPOTHERMIA
14 HYPOTHERMIA-INDUCED*:ME
15 NORMOTHERMIA
16 TEPID
17 COGNITION-DISORDERS:ME
18 COGNITION
19 (COGNITIVE and FUNCTION*)
20 MENTAL-PROCESSES*:ME
21 (CEREBRAL and FUNCTION*)
22 (CEREBRAL and DYSFUNCTION)
23 (CEREBRAL and INJURY)
24 (NEUROPSYCHOLOGICAL and DEFICIT)
25 (NEUROLOGICAL and DEFICIT)
26 MENTAL
27 MEMORY
28 PERSONALITY*:ME
29 PERSONALITY
30 BRAIN-DAMAGE-CHRONIC:ME
31 BRAIN
32 PSYCHOLOGICAL-TESTS*:ME
33 PSYCHOLOGIC*
34 ELECTROENCEPHALOGRAPHY*:ME
35 ELECTROENCEPHALOGRAPH*
36 MAGNETIC-RESONANCE-IMAGING*:ME
37 MRI
38 (MAGNETIC and RESONANCE)
39 CEREBROVASCULAR-DISORDERS*:ME
40 CEREBROVASCULAR
41 EMBOLI*
42 (MICRO and EMBOLI*)
43 NEUROL*
44 ((((((#1 or #2) or #3) or #4) or #5) or #6) or #7)
45 ((((((((#8 or #9) or #10) or #11) or #12) or #13) or #14) or #
15) or #16)
46 ((((((((((#17 or #18) or #19) or #20) or #21) or #22) or #23)
or #24) or #25) or #26) or #27)
47 (((((((((((((((#28 or #29) or #30) or #31) or #32) or #33) or #
34) or #35) or #36) or #37) or #38) or #39) or #40) or #41) or #
42) or #43)
48 (#46 or #47)
49 (#44 or #45)
50 (#48 and #49)
51 (#44 and #45)
52 (#50 or #51)
Data collection and analysis
From the searches, the title and abstract of each paper was reviewed
by one reviewer and potentially relevant references retrieved. Fol-
lowing this initial screening, two reviewers independently selected
trials to be included in this review using predetermined inclu-
sion criteria. In all cases disagreements about any study inclusions
were resolved by consensus. Study outcome data were extracted
independently by two reviewers, and chief investigators of trials
were contacted to provide additional relevant information where
necessary. In addition to study outcome data, trial quality was as-
sessed independently in terms of concealment of allocation, losses
to follow up, blind assessment of outcomes, and adequacy of con-
trol. Data concerning patient characteristics; age, sex, urgent ver-
sus elective CABG, and details of the CABG procedure, the mode
of cardioplegia delivery, and bypass time, were also collected as
stated a priori to perform stratified analysis of the data using meta-
regression.
Dichotomous outcomes for each study have been expressed as odds
ratios and 95% confidence intervals (CI). Continuous variables
have been expressed as the mean change from baseline to follow
up, and the standard deviation difference from baseline to follow
up for each comparison group. Where standard deviation differ-
ences have not been reported in the source papers, allowance has
been made for within patient correlation from baseline to follow
up measurements by using the correlation coefficient between the
two (see Cochrane Heart Group web site for details and, Follmann
1992). A weightedmean difference (WMD) or standardised mean
difference (SMD) and 95%CI have been calculated for each study.
Data from each study were pooled as appropriate using a fixed ef-
fect model, except where substantial heterogeneity existed accord-
ing to the Z statistic, and a random effects model was used (where
a random effects model was used this is indicated in parentheses).
R E S U L T S
Description of studies
See:Characteristics of included studies; Characteristics of excluded
studies.
Details of the studies included in the review are shown in the table
of characteristics of included studies.
Risk of bias in included studies
See also included studies table.
A clear and adequate method of randomization was reported in
11/19 studies. Three of 19 studies reported inadequate random-
ization in that group allocation was alternate, or based on hospital
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numbers. Sensitivity analyses have been performed excluding these
studies and the results are presented below. Blinding of outcome
assessors was considered to be important for those studies with
neurological examination or psychometric testing as an outcome,
rather than those just reporting clinical events. Four of 6 studies
reported blinding of outcome assessors. Losses to follow up did
not occur in most studies which report clinical events in the short
term. One study (Heyer) reported very high losses to follow up
for late psychometric testing at 6-9 weeks post surgery, and these
data have not been included in the review.
Effects of interventions
From the searching, 19 studies reporting separate trials were iden-
tified which met our inclusion criteria. Of these, 13 studies re-
ported hypothermia and normothermia as the primary compar-
ison groups, 4 studies reported the effects of hypothermia, mild
hypothermia or tepid temperature and normothermia, and 2 stud-
ies hypothermia and tepid temperature. Outcome variables were
assessed for the comparison groups hypothermia and normother-
mia as per groupings in the individual trials, and separately for
hypothermia and tepid temperature.
Individual trials recruited patients of very similar mean ages (mean
60.9 years, range across trials 57-65), and the majority of partic-
ipants were men (84% men, range across trials 74-98%). Most
trials excluded patients with neurological deficits. The case mix
of patients across trials were relatively low risk patients with the
exception of one trial that recruited only patients with left ventric-
ular dysfunction (Rashid B).Most patients across trials underwent
elective CABG (mean 14.3% urgent operations, range 0-59%),
with the exception of one trial where the number of urgent cases
exceeded the number of elective cases (Engleman cold).
Clinical outcome variables were assessed only over the short term
within 30 days of the operation.
Clinical events
Hypothermia vs normothermia
The pooled effect estimate showed a reduction in the incidence
of non fatal perioperative strokes in the hypothermic group (OR
0.68 (0.43, 1.05)), although this failed to reach statistical signifi-
cance. Conversely, there was a non significant trend for the num-
ber of non stroke related perioperative deaths to be higher in the
hypothermic group (OR 1.46 (0.9, 2.37)). Hypothermia had no
effect on the incidence of perioperative non fatal myocardial in-
farction (OR 1.05 (0.81, 1.37)). Data were also collected on an-
other more sensitive marker of myocardial damage, low output
syndrome (LOS), which is described as the occurrence of persis-
tent clinically threatening hypotension, and defined as a require-
ment for intra-aortic balloon pump support, or prolonged use of
inotropes postoperatively to maintain systolic blood pressure and
cardiac output. The incidence of low output syndrome in the hy-
pothermic groupwas higher than in the normothermic group (OR
1.21 (0.99, 1.48). Paradoxically, the use of an intra-aortic balloon
pump (IABP) was higher in the normothermic group (OR 0.67
(0.44, 1.03)). When pooling all “bad” outcomes (stroke, periop-
erative death, MI, LOS, IABP) there was no significant advantage
of either hypothermia or normothermia (OR 1.07 (0.92, 1.24)).
Hypothermia vs tepid temperature
Only 5 studies reported non fatal stroke as an outcome. Moderate
hypothermia had no effect on the incidence of perioperative non
fatal stroke (OR 0.94 (0.33, 2.73)), perioperative death (OR 1.94
(0.39, 9.66)), or non fatal MI (OR 0.68 (0.26, 1.81)) compared
to mild hypothermia or tepid temperature.
Psychometric testing to assess cognitive function
Hypothermia vs normothermia
Of the 17 studies in this comparison group, only 4 reported neu-
ropsychological function as an outcome measure. Each trial used
a number of different psychometric tests. Tests have been broadly
divided into those measuring intellectual IQ function, memory,
motor skill or dexterity, and executive function. Those trials which
have used the same tests have been pooled to determine effect size.
Subsets of tests have not been pooled as they often measure dif-
ferent things and respond differently across different age groups.
This is particularly true for the Wechsler Memory Scale (WMS)
(Lezak). A qualitative overview of all of the psychometric tests used
in these trials are presented in Table 1 and Table 2. Results for
both the quantitative and qualitative analysis have been divided
into early tests (within 1 week of the operation) and late tests (1-
3 months post operatively) as reported in the source papers.
For tests of intellectual IQ function and memory, higher scores in-
dicate improved performance, so where mean changes from base-
line to follow up are negative, this indicates a deterioration in per-
formance. The opposite is true for all tests of motor skill/dexterity
and executive function where higher scores show a deterioration
in performance, therefore a mean change from baseline to follow
up which is negative should be interpreted as an improvement in
performance. For these reasons, the sign of the mean change in
intellectual IQ function and memory has been changed for the
pooled analysis so the direction of effect is in the appropriate di-
rection.
No significant neuroprotective effects of hypothermia were seen
for any of the early psychometric tests (within 1 week post op) in
the quantitative analysis, although the numbers of trials in each
comparison group were small. Similarly, no significant effects of
hypothermia were seen for the late psychometric tests (1-3months
post op). The qualitative analysis shows variable responses to dif-
ferent tests for different trials (see Table 1 and Table 2 for early
and late tests respectively). Most tests of cognitive function show
deterioration immediately post operatively which is present in ei-
ther group, or both groups to a similar extent. Conversely, for the
late tests, most trials show an improvement in cognitive function
from baseline to follow up, again individual trials showing variable
responses of hypothermia and normothermia.
Neurological examination
Five trials in the hypothermia vs normothermia group reported
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neurological examination outcomes using a number of different
assessments. The results of these are presented qualitatively in
Table 3.Deterioration in theMathew score, andminimental status
score was seen to a similar extent post surgery in both comparison
groups in the 2 trials that measured each of these as outcomes.
Psychometric testing and neurological examination in the hy-
pothermia vs tepid temperature group
Two trials in this group reported psychometric testing, one for
early tests within 1 week of surgery, and one for late tests at 6
weeks post surgery. Results are presented qualitatively in Table
4. Again, variable responses were seen between hypothermia and
tepid temperature for each of the tests.
Neurological examination was reported in 3 trials in this group
and results are presented qualitatively in Table 5. Deterioration in
the Mathew score was seen 3-4 days post surgery in one trial to a
similar extent in both groups. The mini mental status score was
unchanged in either group in another trial from baseline to 6 days
post surgery.
Health related quality of life
None of the trials reported health related quality of life as an
outcome.
Sensitivity analysis
Sensitivity analyses excluding trials of low methodological quality,
where randomisation was inadequately performed by allocation of
patients on the basis of odd and even hospital numbers, or alter-
nating patients to treatment group, had no effect on the pooled
effect estimate for non fatal strokes (OR 0.65 (0.41, 1.05). Sensi-
tivity analysis excluding studies where the systemic temperature is
similar in both treatment groups has no effect on the pooled effect
estimate for non-fatal strokes (OR 0.66 (0.42, 1.02)).
Stratified analysis
Subgroup analysis was performed to examine the effects of the
method of cardioplegia delivery (either retrograde or antegrade)
on the incidence of non fatal stroke. No significant advantage was
seen with either method, although there were relatively few stud-
ies in each comparison group (retrograde cardioplegia, random
effects model OR 0.68 (0.28, 1.62), antegrade cardioplegia OR
0.84 (0.44, 1.61)). This subgroup analysis was also carried out for
the outcome perioperative deaths where similarly there was no sig-
nificant advantage seen with either method (retrograde cardiople-
gia OR 1.31 (0.56, 3.11), antegrade cardioplegia OR 1.6 (0.87,
2.95)).
Heterogeneity was further explored with the use of meta regres-
sion. Co-variates defined a priori included retrograde or antegrade
delivery of cardioplegia as a dichotomous variable, bypass time
and percentage of patients undergoing urgent rather than elective
surgery. The method of delivery of cardioplegia, or the percentage
of urgent cases within each trial did not significantly affect the
number of non-fatal strokes. The odds ratio for non-fatal strokes
was however significantly affected by the mean time on bypass.
The odds ratio for non-fatal stroke is multiplied by a factor of 1.03
per minute increase in bypass time (coefficient log OR 0.0297,
(CI 0.00387, 0.0555), p=0.024), thus the number of non-fatal
stokes increases with increasing time on bypass.
D I S C U S S I O N
The findings from this systematic review using the current trial ev-
idence cannot demonstrate any clear advantage of either hypother-
mic or normothermic CPB in the occurrence of clinical events.
There is a non significant trend towards fewer strokes in the hy-
pothermic group, but this is counterbalanced by a trend towards
higher perioperative mortality and myocardial damage as shown
by the data on low output syndrome. Conversely, there were no
differences between the groups in the occurrence of MI, possibly
because this is regarded as a relatively crude marker for myocardial
damage.Whenwe examine the pooled “bad” outcomes (including
stroke, perioperative death, MI, LOS and IABP use) there is no
difference in the summary effect estimate between hypothermia
and normothermia.
Individual trials differ in both systemic and cardioplegic tempera-
tures, and the mode of delivery of cardioplegia. These differences,
particularly the mode of cardioplegia delivery, either retrograde or
antegrade, continuous or intermittent,may affect the embolic load
(Baker 1995). Cold cardioplegia was originally used to maintain
cardiac arrest during surgery, and to minimise ischaemic damage.
More recently “warm heart surgery” proposed to be more bene-
ficial in myocardial protection has been introduced whereby the
temperature of the cardioplegia is maintained at 37 degrees and
cardiac arrest during surgery is maintained by the potassium con-
centration in the cardioplegia rather than by hypothermia. Sys-
temic temperatures reflect those of theCPBperfusate, and patients
may be actively warmed, actively cooled or allowed to drift to-
wards mild hypothermia, depending on the protocol. Retrograde
delivery of the cardioplegia via the coronary sinus prevents distal
embolization of coronary or graft debris, and is recommended for
redo CABG, and for tight coronary stenoses (Loop 1992). Car-
dioplegia can be distributed to the myocardium regardless of the
state of the native vessels, and flooding of the operative field is
reduced, allowing more continuous flow. Retrograde cardioplegia
has also been reported to result in a higher incidence of emboli
immediately after release of the aortic cross clamp compared with
antegrade cardioplegia (Baker 1995). Antegrade delivery of car-
dioplegia is accomplished via the ascending aorta. Flow is neces-
sarily limited in myocardial regions served by severely occluded
coronary arteries.
In an attempt to determine the effects of retrograde or antegrade
delivery of cardioplegia on the incidence of stroke, we have per-
formed subgroup analyses, and meta regression. No significant ad-
vantage of either method was seen, although the number of trials
in each group were small. Similarly, meta regression failed to show
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a relationship between effect size and mode of cardioplegia deliv-
ery. The systemic temperature rather than cardioplegia tempera-
ture is more important in terms of neuroprotection. The group
allocation to hypothermia or normothermia in all but 2 trials re-
flected the systemic temperature rather than cardioplegia temper-
ature. Sensitivity analyses excluding these trials had little effect on
the summary effect estimate for non fatal strokes.
The clinical event data contributing to the current meta-analy-
sis is dominated by 2 multi centre RCTs, the study from Emory
(Martin (Emory)) and the Warm Heart Investigators in Toronto
(Warm Heart). To date, these are the only RCTs of warm versus
cold surgery of sufficient power to detect possible differences in the
stroke rate. The warm heart investigators found no difference in
the rate of strokes or MI, less frequent low output syndrome, and
a trend towards reduced perioperative mortality in the normoth-
ermic versus hypothermic groups. Conversely, the Emory series
found no relative advantages of normothermia, but a significantly
increased stroke rate which lead to early termination of the study.
A number of factors may explain these opposing results, partic-
ularly the operative technique and the patient population. The
Emory trial used continuous retrograde warm blood cardioplegia
versus intermittent cold oxygenated crystalloid cardioplegia. Pa-
tients were actively warmed or cooled to maintain systemic nor-
mothermia or hypothermia respectively. The total number of ad-
verse neurological events were 1.4% in the cold group, and 4.5%
in the warm group. Multivariate analysis was used to determine
predictors of stoke in this group of patients. Preoperative conges-
tive heart failure, age, aortic cross clamp time and use of warm ret-
rograde cardioplegia were all significantly associated with stroke.
Differences in the stroke rate were non existent in patients under
60, twice as likely in the warm blood patients between the ages of
60-69, and five times as high in warm blood patients over the age
of 70 (Guyton 1995).
In the warmheart investigators trial there were fewer women (16%
vs 25%), fewer patients over the age of 70 (16% vs 30%), and
fewer higher risk patients for re operations (14% vs 4%). Dif-
ferences in the patient populations alone may explain the higher
incidence of strokes in the Emory series. However, cardioplegia
in both the warm and cold blood groups was primarily antegrade
(94% of patients) in the warm heart investigators trial, whereas
in the Emory trial patients received warm retrograde continuous
cardioplegia. Warm patients in the warm heart investigators trial
were not actively warmed to maintain systemic normothermia as
in the Emory series, but rather allowed to drift to 33 degrees, so
it is possible that a significant proportion of patients in this group
were mildly hypothermic. Small differences in systemic tempera-
ture may affect the susceptibility of the brain to cerebral emboli
due to differences in metabolic rate and cerebral blood flow.
In response to the different results foundwith normothermicCPB,
tepid or mild hypothermic CPB has been proposed as a possible
compromise. Only 5 trials totaling nearly 500 patients reported
stroke as an outcome in this group, so there was insufficient power
to detect differences between groups.
Across all trials, meta regression was used to examine the effects of
cardioplegia delivery asmentioned previously, but also the number
of urgent rather than elective procedures, and bypass time on the
incidence of strokes. The effect size was unrelated to the mode of
cardioplegia delivery, or the number of urgent procedures. Mean
bypass time was however associated with the incidence of strokes,
where the number of strokes increases with increasing time on by-
pass. This finding is however based on mean trial data rather than
individual patient data and should be interpreted with caution.
Other potentially important co-variates include variability in co-
interventions and operative techniques, volumes and flow rates of
cardioplegia, individual patient systemic temperatures, and sur-
geon specific outcomes.
Subtle neurological deficits detected by neurological examination
or psychometric testing, and quality of life measures, have been
considered important outcomes of CABG with the reduction in
stroke rates over the years. Unfortunately very few trials reported
these as outcomes, and in those that did, several differentmeasures/
scales were used which makes interpretation of findings between
trials difficult. None of the trials included in this review reported
quality of life as an outcome.
A U T H O R S ’ C O N C L U S I O N S
Implications for practice
This review could find no definite advantage of hypothermia over
normothermia in the incidence of clinical events. Hypothermia
was associated with a reduced stroke rate, but this is off set by a
trend towards an increase in perioperative mortality and myocar-
dial damage. There is insufficient trial evidence to date to draw any
conclusions about the use of tepid CPB. Similarly, no conclusions
can be made concerning the effect of temperature on more subtle
neurological deficits due to lack of data.
Implications for research
To date only 2 trials included within this review are of sufficient
power to detect differences in the stroke rate between hypother-
mia and normothermia. Differences in operative techniques and
patient population may explain the contradictions found between
these 2 trials. Further trials are required of standard format to re-
solve some of these discrepancies, perhaps with the use of tepid
CPB given the high stroke rate reported in the Emory series. There
is insufficient data to date to comment on the effect of temperature
during CPB on subtle neurological deficits and further trials are
needed in this area. Similarly, health related quality of life which is
an important outcome has not been reported in any trial to date,
and future trials should address this.
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C H A R A C T E R I S T I C S O F S T U D I E S
Characteristics of included studies [ordered by study ID]
Birdi cold
Methods Randomisation by card allocation to one of three groups.
Participants 300 patients (35 women) randomised to cold, tepid or warm CPB. Mean age 60 years. 88% patients for elective
CABG
Interventions CPB perfusate temperature maintained to give a target nasopharyngeal temperature of 28 degrees, 32 degrees, or 37
degrees for the cold, tepid and warm groups respectively.Myocardial protection achieved by cold antegrade crystalloid
cardioplegia and topical cooling
Outcomes Stroke (defined by neurologic examination), perioperative death, MI, IABP
Notes Excluded patients with previous stroke or TIA
Birdi tepid
Methods Same study as Birdi cold. Comparison groups cold vs tepid.
Participants Same study as Birdi cold. Comparison groups cold vs tepid.
Interventions Same study as Birdi cold. Comparison groups cold vs tepid.
Outcomes Same study as Birdi cold. Comparison groups cold vs tepid.
Notes Same study as Birdi cold. Comparison groups cold vs tepid.
Cook
Methods Method of randomisation unclear.
Participants 60 patients randomised to cold or warm CPB. No details regarding age and sex. All patients elective first time CABG
Interventions CPB perfusate temperature maintained to give a target nasopharyngeal temperature of 28 degrees and 37 degrees
repectively for the cold and warm group
Outcomes Stroke (defined as a focal neurologic deficit), MI
Notes Excluded patients with prior CVD or diabetes.
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Engleman cold
Methods Patients randomised to 3 CPB temperatures, cold, tepid and warm using a randomnumber table and sealed envelopes.
Outcome assessors of neurological tests were blind to group allocation. Comparison group cold vs warm
Participants 291 patients randomised (24% women). Mean age 62.8 years. 41% patients for elective surgery
Interventions 3 perfusate temperatures, cold (20 degrees), tepid (32 degrees) and warm (37 degrees) for CPB in association with
3 myocardial preservation temps, cold (8-12 degrees), tepid (32 degrees) and warm (37 degrees) cardioplegia. 3/4
surgeons administered antegrade-retrograde cardioplegia, one surgeon used only retrograde cardioplegia
Outcomes Stroke (defined by neurological examination and CT scan), perioperative death, MI, Matthew score - neurological
assessment including cognitive function, elemental examination and degree of disability. Matthew score measured at
3-4 days postop and 1 month post op
Notes Excluded patients >76 years, patients with any history of neurological dysfunction, and patients with LVEF <30%
Engleman tepid
Methods Same study as Engleman cold. Comparison groups cold vs tepid
Participants Same study as Engleman cold. Comparison groups cold vs tepid
Interventions Same study as Engleman cold. Comparison groups cold vs tepid
Outcomes Same study as Engleman cold. Comparison groups cold vs tepid
Notes Same study as Engleman cold. Comparison groups cold vs tepid
Fiore
Methods Method of randomisation unclear.
Participants 52 patients randomised (12 women). Mean age 64.7 years. All for elective CABG
Interventions Intermittant antegrade cold blood cardioplegia (4 degrees) vs intermittent antegrade tepid blood cardioplegia (29
degrees). Systemic temperature was allowed to drift to 32 degrees in both groups
Outcomes Stroke (defined as transcient neurologic deficit).
Notes
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Hayashida cold A
Methods Patients randomised by means of a computer generated randomisation table.
Comparison group cold antegrade vs warm antegrade.
Participants 72 patients (7 women) randomised to 6 groups: cold, tepid and warm, antegrade and retrograde cardioplegia. Mean
age 60.3 years (range 35-79). 32% of patients for urgent CABG
Interventions 6 cardioplegic strategies:
Cold antegrade cardioplegia (8 degrees), cold retrograde caridioplegia (8 degrees), warm antegrade cardioplegia (37
degrees), warm retrograde cardioplegia (37 degrees), tepid antegrade cardioplegia (allowed to drift to 29 degrees),
tepid retrograde cardioplegia (allowed to drift to 29 degrees). Systemic temperatures for all groups were allowed to
drift to 33 degrees
Outcomes Stroke (defined as transcient neurologic deficit), perioperative death, MI, LOS (defined as requirement for inotrophic
medication or balloon pump support), IABP
Notes
Hayashida cold R
Methods Same study as Hayashida cold A.
Comparison group cold retrograde vs warm retrograde.
Participants Same study as Hayashida cold A.
Comparison group cold retrograde vs warm retrograde.
Interventions Same study as Hayashida cold A. Comparison group cold retrograde vs warm retrograde
Outcomes Same study as Hayashida cold A.
Comparison group cold retrograde vs warm retrograde.
Notes Same study as Hayashida cold A. Comparison group cold retrograde vs warm retrograde
Hayashida tepid A
Methods Same study as Hayashida cold A. Comparison group cold antegrade vs tepid antegrade
Participants Same study as Hayashida cold A. Comparison group cold antegrade vs tepid antegrade
Interventions Same study as Hayashida cold A. Comparison group cold antegrade vs tepid antegrade
Outcomes Same study as Hayashida cold A. Comparison group cold antegrade vs tepid antegrade
Notes Same study as Hayashida cold A. Comparison group cold antegrade vs tepid antegrade
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Hayashida tepid R
Methods Same study as Hayashida cold A. Comparison group cold retrograde vs tepid retrograde
Participants Hayashida cold A. Comparison group cold retrograde vs tepid retrograde
Interventions Hayashida cold A. Comparison group cold retrograde vs tepid retrograde
Outcomes Hayashida cold A. Comparison group cold retrograde vs tepid retrograde
Notes Hayashida cold A. Comparison group cold retrograde vs tepid retrograde
Heyer
Methods Consecutive patients randomised to moderate or mild hypothermia. Stratified randomisation according to age. Not
stated whether outcome assessors were blind to group allocation
Participants 99 patients randomised (18 women). Mean age 64 years. All patients for elective surgery undergoing first procedures
Interventions Moderate hypothermic (target nasopharyngeal temp 28 degrees) vs mild hypothermic CPB (target nasopharyngeal
temp 34 degrees). Antegrade and retrograde cold blood cardioplegia used in both groups
Outcomes Neurologic and neuropsychometric exam pre and post op. Neuropsychometric tests included trails A and B, repetitive
tapping, grooved pegboard and Busche memory tests. Data has been analysed for early tests at 6 days post op, but
not late tests (6-9 weeks post hospital discharge) due to high loss to follow up
Notes Excluded patients prior to randomisation with evidence of neurologic or psychiatric disease
Kadoi
Methods Consecutive patients randomised to either hypothermic or normothermic CPB, method of randomisation unclear
Participants 30 patients randomised. Mean age 64 years. All for elective CABG
Interventions Hypothermic (target nasopharyngeal temp 30 degrees) vs normothermic (target nasopharyngeal temp >35 degrees)
CPB. Intermittant antegrade blood cardioplegia (37 degrees warm group, 5 degrees cold group)
Outcomes Mini mental status tests done preoperatively and 7 days post operatively (unpublished data kindly provided by the
authors)
Notes No pre-existing CVD
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Lajos
Methods Method of randomisation unclear “patients were alternated...”
Participants 108 (28 women) patients randomised to cold blood or warm blood cardioplegia. Mean age 64 years
Interventions Cold blood retrograde and antegrade cardioplegia vs warm retrograde and antegrade cardioplegia (temp 37 degrees).
Systemic temperature lowered to 30 degrees in the cold group, and maintained at 36-37 degrees in the warm group
Outcomes Stroke (not defined), perioperative death, MI, IABP.
Notes 55 further patients randomised to cold crystalloid cardioplegia. These have not been included in this analysis due to
the lack of an appropriate comparison group
Landymore
Methods Patients randomised to either warm or cold blood cardioplegia by a computer generated series of random numbers
Participants 40 patients randomised. Mean age 57.5 years. All elective surgery
Interventions Antegrade warm (37 degrees) or antegrade cold blood (8 degrees) cardioplegia. Systemic temperature maintained at
37 degrees (nasopharyngeal temp) during CPB in both groups
Outcomes Stroke, MI, perioperative death, LOS and IABP as defined by use of inotropes and IABP use
Notes Patients included if they had 3 vessel CAD and had LVEF>25%. Excluded patients who had undergone prior cardiac
operations, or who required concomitant surgery
Martin (Emory)
Methods 2 center RCT (Emory). Patients randomised by computer generated random number assignment
Participants 1001 patients randomised (24.5% women). Mean age 63.3. All elective surgery. 14.4% patients had prior CABG
Interventions Continuous warm retrograde blood cardioplegia (>35 degrees, with systemic normothermia - >35 degrees) vs inter-
mittant antegrade cold crystalloid cardioplegia (<8 degrees, with systemic hypothermia - <28 degrees)
Outcomes Stroke (defined as a persistent central neurologic deficit), perioperative death, MI, LOS (inferred from inotrophic
drug use), IABP use. Substudy re: Mora examined neuropsychometric data at 1 week and 4-6 weeks post op in a
subgroup of 138 patients
Notes
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McLean (Warm Heart)
Methods As for Warm Heart Investigators.
Outcome assessors of psychometric tests were blind to group allocation
Participants 201 patients. Mean age 58.7.
Interventions As for Warm Heart Investigators.
Outcomes Neuropsychometric tests at 4-5 days post op, and 3months post op. Tests included Trails A and B,WAIS revised digit
symbol, WMS revised visual reproduction, Buschke total recall test and long term retrieval and grooved pegboard
Notes Substudy of Warm Heart Investigators RCT.
Mora (Emory)
Methods As for Martin.
Outcome assessors of psychometric tests were blind to group allocation
Participants 138 patients (22% women). Mean age 63 years.
Interventions As for Martin.
Outcomes Neurological assessment and neuropsychometric assessment. Tests includedWAIS digit span and digit symbol,WMS
associate learning and mental control, and grooved pegboard. Tests were carried out at 1 week and 4-6 weeks post op
Notes Substudy of Emory RCT. 12% patients had a previous stroke in the cold group, 3% in the warm group
Pelletier
Methods Patients randomised in blocks of 4 for equal sample size in the 2 groups
Participants 200 patients randomised (42 women). Mean age 61 years (40-80 years)
Interventions Intermittant antegrade warm blood cardioplegia vs intermittant antegrade cold blood cardioplegia. Systemic tem-
perature during CPB allowed to drift to 33-34 degrees in both groups
Outcomes Stroke (defined as clinical presentation of the individual patient), perioperative death,MI, LOS (defined as inotrophic
drug use) and IABP
Notes Excluded patients having ops within 7 days acute MI, urgent ops, reops, and coronary ops associated with any other
surgical procedure
18Hypothermia to reduce neurological damage following coronary artery bypass surgery (Review)
Copyright © 2013 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.
Plourde
Methods Randomisation by sequentially numbered sealed envelopes. Outcome assessors of psychometric tests were blind to
group allocation
Participants 62 patients (4 women) randomised to cold or warm CPB . Mean age 57 years. All for elective surgery
Interventions CPB perfusate temperature maintained to give a target nasopharyngeal temperature of 28 degrees and 34-35 degrees
in the cold and warm groups respectively. Intermittant antegrade cold blood cardioplegia (4 degrees) used for all
patients, except for 6 in the warm group who recieved continuous warm blood cardioplegia
Outcomes Stroke (not defined), perioperative death,MI. Psychometric testing 1 week post op. Tests includedWAIS information
subset, picture and completion subset, and digit span subset, COWAT, Trailmaking B
Notes Excluded patients who had had prior cardiac surgery, CVD, or LVEF<0.4. Further data available for subsets of the
WMS, but different versions of the tests were used pre and post operatively so data have not been collected
Rashid A
Methods Consecutive patients randomised according to hospital numbers
Participants 281 patients (70 women). Mean age 60.2. 63% patients for elective surgery
Interventions Moderate systemic hypothermia (nasopharyngeal temp 28 degrees, cardioplegic temp 4-6 degrees) vs normothermia
(nasopharyngeal temp 37 degrees). Retrograde continuous warm and intermittant cold blood cardioplegia
Outcomes Stroke (not defined), MI, perioperative death. LOS (inferred with inotrope use) and IABP use
Notes
Rashid B
Methods Consecutive patients randomised according to hospital numbers
Participants 108 patients (20 women). Median age 59 years. 72% patients for elective surgery
Interventions Moderate systemic hypothermia (nasopharyngeal temp 28 degrees, cardioplegic temp 8 degrees) vs normothermia
(nasopharyngeal temp 37 degrees). Retrograde continuous warm and intermittant cold blood cardioplegia
Outcomes Stroke (defined as CVA - stroke and confusion), MI, perioperative death. LOS and IABP use
Notes Patients selected prior to randomisation for moderate to severe left ventricular dysfunction (CASS score 14-15)
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Regragui cold
Methods Patients randomised by using a random number table. Comparison group cold vs warm CPB
Participants 96 patients (12 women) randomised to one of 3 groups, cold, tepid or warm CPB. Mean age 59 years. 24% patients
for urgent CABG
Interventions CPB perfusate temperature maintained to give a target nasopharyngeal temperature of 28 degrees, 32 degrees, or 37
degrees for the cold, tepid and warm groups respectively.Myocardial protection achieved by cold antegrade crystalloid
cardioplegia and topical cooling
Outcomes Perioperative death, neurological examination and psychometric testing at 6 weeks post surgery. Psychometric tests
included WAIS digit span, picture arrangement, block design, object assembly and digit symbol, and WMS verbal
and visual paired associates
Notes Excluded patients with previous neurologic disease or psychiatric illness
Regragui tepid
Methods Same study as Regragui cold. Comparison group cold vs tepid CPB
Participants Same study as Regragui cold. Comparison group cold vs tepid CPB
Interventions Same study as Regragui cold. Comparison group cold vs tepid CPB
Outcomes Same study as Regragui cold. Comparison group cold vs tepid CPB
Notes Same study as Regragui cold. Comparison group cold vs tepid CPB
Tonz
Methods Consecutive patients randomised, no method stated.
Participants 30 patients (2 women). Mean age 61.5 years. All for elective surgery, all first procedures
Interventions Moderate systemic hypothermia (blood temperature 26-28 degrees) vs normothermia (36-37 degrees). Management
of myocardial protection was identical in both groups - cold intermittant blood cardioplegia administered either
retrogradely, antegradely or both
Outcomes Stroke (defined as cerebrovascular insult), perioperative death
Notes Excluded patients >65 years, and ejection fraction <0.35, and any previous cardiac procedure
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Warm Heart
Methods 3 center RCT (Toronto). Treatment allocation by sealed envelope, stratified by surgeon and urgent vs elective cases
Participants 1732 patients (285 women). Mean age 61 years (40-80 years). 74% elective cases
Interventions Warm antegrade cardioplegia (37 degrees) vs cold antegrade cardioplegia (5-8 degrees). 6.3% of patients recieved
at least some retrograde cardioplegia. Target systemic temperature in the warm group kept between 33-37 degrees).
Target systemic temperature in the cold group reduced to 25-28 degrees by active cooling
Outcomes Stroke (defined as persistent central neurologic deficit), perioperative death, MI, LOS (use of inotropic medication
or IABP for 60 mins + to sustain SBP>90mmHg), IABP use. Substudy re: McLean looked at neurological and
neuropsychological function at 5 days and 3 months post op in 201 patients
Notes 5.5% patients had had a previous TIA or stroke.
Excluded patients scheduled for concomitant cardiac surgical or vascular procedures
Yau A cold A
Methods Patients randomised using computer generated randomisation table
Participants 107 (8 women) patients randomised to 5 groups: cold antegrade, cold retrograde, warm antegrade, warm retrograde
and intermittant cold cardioplegia. Mean age 59 years. 89% patients underwent elective surgery
Interventions 5 cardioplegic strategies:
Warm antegrade cardioplegia (37 degrees), warm retrograde cardioplegia (37 degrees), cold antegrade cardioplegia (5
degrees), cold intermittant antegrade cardioplegia (5 degrees) and cold retrograde cardioplegia (5 degrees). In patients
recieving warm cardioplegia systemic temps were allowed to drift to 30 degrees, patients recieving cold cardioplegia
were actively cooled to 28 degrees
Outcomes Stroke (not defined), perioperative death, MI, LOS (defined as IABP use), IABP
Notes
Yau A cold int. A
Methods As for Yau cold A. Comparison group intermittant cold antegrade cardioplegia vs warm antegrade cardioplegia
Participants As for Yau cold A. Comparison group intermittant cold antegrade cardioplegia vs warm antegrade cardioplegia
Interventions As for Yau cold A. Comparison group intermittant cold antegrade cardioplegia vs warm antegrade cardioplegia
Outcomes As for Yau cold A. Comparison group intermittant cold antegrade cardioplegia vs warm antegrade cardioplegia
Notes As for Yau cold A. Comparison group intermittant cold antegrade cardioplegia vs warm antegrade cardioplegia
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Yau A cold R
Methods As for Yau cold A. Comparison group cold retrograde cardioplegia vs warm retrograde cardioplegia
Participants As for Yau cold A. Comparison group cold retrograde cardioplegia vs warm retrograde cardioplegia
Interventions As for Yau cold A. Comparison group cold retrograde cardioplegia vs warm retrograde cardioplegia
Outcomes As for Yau cold A. Comparison group cold retrograde cardioplegia vs warm retrograde cardioplegia
Notes As for Yau cold A. Comparison group cold retrograde cardioplegia vs warm retrograde cardioplegia
Yau B
Methods Patients randomised using computer generated randomisation table
Participants 53 (1 female) patients randomised. Mean age 58.5 years. All elective CABG, with stable exertional angina
Interventions Warm continuous antegrade blood cardioplegia vs antegrade intermittant cold blood cardioplegia. Systemic temper-
ature in the warm group allowed to drift to 30-32 degrees, patients in the cold group were actively cooled to 25-28
degrees
Outcomes Stroke (not defined), perioperative death, MI, LOS (defined as inotropic drug use or IABP use), IABP
Notes
CABG - coronary artery bypass graft
CASS - coronary artery surgery study
CVD - cerebrovascular disease
CPB - cardiopulmonary bypass
IABP - intra-aortic balloon pump use
LOS - low output syndrome
LVEF - left ventricular ejection fraction
MI - myocardial infarction
TIA - transcient ischaemic attack
Psychometric tests:
COWART - control oral word association test
WAIS - Wechsler Adult Intelligence Scale
WMS - Wechsler Memory Scale
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Characteristics of excluded studies [ordered by study ID]
Study Reason for exclusion
Arom Tepid vs warm temperature protocol.
Birdi No neurological outcomes measured.
Chello No neurological outcomes measured.
Christakis No neurological outcomes measured.
Christakis 2 No neurological outcomes measured.
Craver Not a randomised controlled trial.
Elwatidy No neurological outcomes measured.
Frank No neurological outcomes measured.
Gozal No neurological outcomes measured.
Grech No neurological outcomes measured.
Guiraudon No neurological outcomes measured. Both comparison groups used hypothermia, mode of cardioplegia delivery, either
antegrade or retrograde was the focus of this study
Hayashida No neurological outcomes measured.
Kaukoranta Tepid vs warm temperature protocol.
Nathan No neurological outcomes measured.
Regragui No neurological outcomes measured.
Yau No neurological outcomes measured.
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D A T A A N D A N A L Y S E S
Comparison 1. Hypothermia versus normothermia
Outcome or subgroup title
No. of
studies
No. of
participants Statistical method Effect size
1 Non fatal stroke 18 4249 Peto Odds Ratio (Peto, Fixed, 95% CI) 0.68 [0.44, 1.05]
2 Perioperative deaths (not strokes) 16 4201 Peto Odds Ratio (Peto, Fixed, 95% CI) 1.46 [0.90, 2.37]
3 Non fatal MI 17 4219 Peto Odds Ratio (Peto, Fixed, 95% CI) 1.05 [0.81, 1.37]
4 Low output syndrome (LOS) 13 3711 Peto Odds Ratio (Peto, Fixed, 95% CI) 1.21 [0.99, 1.48]
5 Intra-aortic balloon pump use
(IABP)
13 3949 Peto Odds Ratio (Peto, Fixed, 95% CI) 0.67 [0.44, 1.03]
6 Pooled “bad” outcomes
(perioperative death, stroke,
MI, LOS, IABP)
19 4311 Peto Odds Ratio (Peto, Fixed, 95% CI) 1.07 [0.92, 1.24]
7 Early cognitive function tests 4 1546 Mean Difference (IV, Fixed, 95% CI) -0.43 [-1.49, 0.63]
7.1 Intellectual IQ function -
WAIS RDS
3 297 Mean Difference (IV, Fixed, 95% CI) -0.94 [-3.38, 1.50]
7.2 Intellectual IQ function -
digit span
2 146 Mean Difference (IV, Fixed, 95% CI) -0.70 [-1.98, 0.58]
7.3 Memory - Buschke
consistent longterm retrieval
2 241 Mean Difference (IV, Fixed, 95% CI) -0.72 [-8.53, 7.08]
7.4 Motor skill / dexterity -
Trails A
2 241 Mean Difference (IV, Fixed, 95% CI) 2.29 [-1.58, 6.17]
7.5 Motor skill / dexterity -
Grooved Pegboard
3 326 Mean Difference (IV, Fixed, 95% CI) 3.49 [-5.33, 12.31]
7.6 Executive function - Trails
B
3 295 Mean Difference (IV, Fixed, 95% CI) 2.27 [-8.43, 12.98]
8 Late cognitive function tests 3 811 Mean Difference (IV, Fixed, 95% CI) -0.23 [1.00, 0.55]
8.1 Intellectual IQ function -
WAIS RDS
3 297 Mean Difference (IV, Fixed, 95% CI) -0.32 [-2.20, 1.57]
8.2 Intellectual IQ function -
digit span
2 144 Mean Difference (IV, Fixed, 95% CI) -0.08 [-1.21, 1.05]
8.3 Memory - WMS verbal
paired associates / associated
learning
2 133 Mean Difference (IV, Fixed, 95% CI) -0.35 [-1.64, 0.94]
8.4 Motor skill / dexterity -
Grooved Pegboard
2 237 Mean Difference (IV, Fixed, 95% CI) -1.28 [-10.01, 7.45]
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Comparison 2. Hypothermia versus tepid temperature or mild hypothermia
Outcome or subgroup title
No. of
studies
No. of
participants Statistical method Effect size
1 Non fatal stroke 5 493 Peto Odds Ratio (Peto, Fixed, 95% CI) 0.94 [0.33, 2.73]
2 Perioperative deaths (not strokes) 3 460 Peto Odds Ratio (Peto, Fixed, 95% CI) 1.94 [0.39, 9.66]
3 Non fatal MI 4 441 Peto Odds Ratio (Peto, Fixed, 95% CI) 0.68 [0.26, 1.81]
Comparison 3. Hypothermia versus normothermia, retrograde delivery of cardioplegia
Outcome or subgroup title
No. of
studies
No. of
participants Statistical method Effect size
1 Non fatal stroke 6 1720 Peto Odds Ratio (Peto, Fixed, 95% CI) 0.55 [0.32, 0.97]
2 Perioperative deaths (not strokes) 4 1588 Peto Odds Ratio (Peto, Fixed, 95% CI) 1.31 [0.56, 3.11]
Comparison 4. Hypothermia versus normothermia, antegrade delivery of cardioplegia
Outcome or subgroup title
No. of
studies
No. of
participants Statistical method Effect size
1 Non fatal stroke 5 2237 Peto Odds Ratio (Peto, Fixed, 95% CI) 0.93 [0.47, 1.85]
2 Perioperative deaths (not strokes) 5 2237 Peto Odds Ratio (Peto, Fixed, 95% CI) 1.82 [0.97, 3.40]
25Hypothermia to reduce neurological damage following coronary artery bypass surgery (Review)
Copyright © 2013 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.
Analysis 1.1. Comparison 1 Hypothermia versus normothermia, Outcome 1 Non fatal stroke.
Review: Hypothermia to reduce neurological damage following coronary artery bypass surgery
Comparison: 1 Hypothermia versus normothermia
Outcome: 1 Non fatal stroke
Study or subgroup Treatment Control
Peto
Odds Ratio Weight
Peto
Odds Ratio
n/N n/N Peto,Fixed,95% CI Peto,Fixed,95% CI
Birdi cold 0/100 1/100 1.2 % 0.14 [ 0.00, 6.82 ]
Cook 0/30 0/30 Not estimable
Engleman cold 6/100 4/98 11.8 % 1.49 [ 0.42, 5.30 ]
Hayashida cold A 0/12 0/12 Not estimable
Hayashida cold R 0/12 1/12 1.2 % 0.14 [ 0.00, 6.82 ]
Lajos 0/54 3/54 3.6 % 0.13 [ 0.01, 1.28 ]
Landymore 0/20 0/20 Not estimable
Martin (Emory) 6/508 20/493 31.2 % 0.32 [ 0.15, 0.70 ]
Pelletier 2/100 1/100 3.7 % 1.96 [ 0.20, 19.07 ]
Plourde 0/29 1/33 1.2 % 0.15 [ 0.00, 7.76 ]
Rashid A 4/144 2/137 7.3 % 1.87 [ 0.37, 9.43 ]
Rashid B 2/50 2/58 4.8 % 1.17 [ 0.16, 8.56 ]
Tonz 0/16 0/14 Not estimable
Warm Heart 13/872 14/860 32.8 % 0.91 [ 0.43, 1.96 ]
Yau A cold A 0/20 0/21 Not estimable
Yau A cold int. A 1/22 0/21 1.2 % 7.06 [ 0.14, 356.21 ]
Yau A cold R 0/22 0/22 Not estimable
Yau B 0/26 0/27 Not estimable
Total (95% CI) 2137 2112 100.0 % 0.68 [ 0.44, 1.05 ]
Total events: 34 (Treatment), 49 (Control)
Heterogeneity: Chi2 = 13.48, df = 10 (P = 0.20); I2 =26%
Test for overall effect: Z = 1.72 (P = 0.086)
Test for subgroup differences: Not applicable
0.1 0.2 0.5 1 2 5 10
Favours treatment Favours control
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Analysis 1.2. Comparison 1 Hypothermia versus normothermia, Outcome 2 Perioperative deaths (not
strokes).
Review: Hypothermia to reduce neurological damage following coronary artery bypass surgery
Comparison: 1 Hypothermia versus normothermia
Outcome: 2 Perioperative deaths (not strokes)
Study or subgroup Treatment Control
Peto
Odds Ratio Weight
Peto
Odds Ratio
n/N n/N Peto,Fixed,95% CI Peto,Fixed,95% CI
Birdi cold 2/100 1/100 4.5 % 1.96 [ 0.20, 19.07 ]
Engleman cold 1/100 1/98 3.0 % 0.98 [ 0.06, 15.78 ]
Lajos 0/54 2/54 3.0 % 0.13 [ 0.01, 2.15 ]
Landymore 0/20 1/20 1.5 % 0.14 [ 0.00, 6.82 ]
Martin (Emory) 8/508 5/493 19.4 % 1.55 [ 0.52, 4.62 ]
Pelletier 1/100 1/100 3.0 % 1.00 [ 0.06, 16.10 ]
Plourde 0/29 0/33 Not estimable
Rashid A 3/144 1/137 6.0 % 2.61 [ 0.36, 18.77 ]
Rashid B 0/50 2/58 3.0 % 0.15 [ 0.01, 2.49 ]
Regragui cold 1/31 0/29 1.5 % 6.93 [ 0.14, 349.88 ]
Tonz 0/16 0/14 Not estimable
Warm Heart 22/872 12/860 50.5 % 1.80 [ 0.91, 3.54 ]
Yau A cold A 0/20 0/21 Not estimable
Yau A cold int. A 1/22 0/21 1.5 % 7.06 [ 0.14, 356.21 ]
Yau A cold R 0/22 1/22 1.5 % 0.14 [ 0.00, 6.82 ]
Yau B 1/26 0/27 1.5 % 7.68 [ 0.15, 387.26 ]
Total (95% CI) 2114 2087 100.0 % 1.46 [ 0.90, 2.37 ]
Total events: 40 (Treatment), 27 (Control)
Heterogeneity: Chi2 = 11.02, df = 12 (P = 0.53); I2 =0.0%
Test for overall effect: Z = 1.55 (P = 0.12)
Test for subgroup differences: Not applicable
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Analysis 1.3. Comparison 1 Hypothermia versus normothermia, Outcome 3 Non fatal MI.
Review: Hypothermia to reduce neurological damage following coronary artery bypass surgery
Comparison: 1 Hypothermia versus normothermia
Outcome: 3 Non fatal MI
Study or subgroup Treatment Control
Peto
Odds Ratio Weight
Peto
Odds Ratio
n/N n/N Peto,Fixed,95% CI Peto,Fixed,95% CI
Birdi cold 6/100 6/100 5.2 % 1.00 [ 0.31, 3.20 ]
Cook 0/30 0/30 Not estimable
Engleman cold 1/100 1/98 0.9 % 0.98 [ 0.06, 15.78 ]
Hayashida cold A 0/12 0/12 Not estimable
Hayashida cold R 0/12 0/12 Not estimable
Lajos 1/54 2/54 1.3 % 0.51 [ 0.05, 4.98 ]
Landymore 1/20 1/20 0.9 % 1.00 [ 0.06, 16.58 ]
Martin (Emory) 4/508 6/493 4.5 % 0.65 [ 0.19, 2.25 ]
Pelletier 4/100 2/100 2.7 % 1.98 [ 0.39, 10.02 ]
Plourde 0/29 0/33 Not estimable
Rashid A 7/144 8/137 6.5 % 0.82 [ 0.29, 2.33 ]
Rashid B 2/50 3/58 2.2 % 0.77 [ 0.13, 4.61 ]
Warm Heart 93/872 85/860 73.1 % 1.09 [ 0.80, 1.48 ]
Yau A cold A 1/20 0/21 0.5 % 7.77 [ 0.15, 391.93 ]
Yau A cold int. A 1/22 0/21 0.5 % 7.06 [ 0.14, 356.21 ]
Yau A cold R 0/22 1/22 0.5 % 0.14 [ 0.00, 6.82 ]
Yau B 2/26 1/27 1.3 % 2.08 [ 0.21, 20.93 ]
Total (95% CI) 2121 2098 100.0 % 1.05 [ 0.81, 1.37 ]
Total events: 123 (Treatment), 116 (Control)
Heterogeneity: Chi2 = 5.24, df = 12 (P = 0.95); I2 =0.0%
Test for overall effect: Z = 0.38 (P = 0.70)
Test for subgroup differences: Not applicable
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Analysis 1.4. Comparison 1 Hypothermia versus normothermia, Outcome 4 Low output syndrome (LOS).
Review: Hypothermia to reduce neurological damage following coronary artery bypass surgery
Comparison: 1 Hypothermia versus normothermia
Outcome: 4 Low output syndrome (LOS)
Study or subgroup Treatment Control
Peto
Odds Ratio Weight
Peto
Odds Ratio
n/N n/N Peto,Fixed,95% CI Peto,Fixed,95% CI
Engleman cold 22/100 19/98 8.7 % 1.17 [ 0.59, 2.33 ]
Hayashida cold A 0/12 1/12 0.3 % 0.14 [ 0.00, 6.82 ]
Hayashida cold R 0/12 0/12 Not estimable
Landymore 2/20 4/20 1.4 % 0.47 [ 0.08, 2.58 ]
Martin (Emory) 73/508 73/493 33.3 % 0.97 [ 0.68, 1.37 ]
Pelletier 23/100 17/100 8.6 % 1.45 [ 0.73, 2.90 ]
Rashid A 29/144 23/137 11.4 % 1.25 [ 0.68, 2.28 ]
Tonz 1/16 2/14 0.7 % 0.42 [ 0.04, 4.43 ]
Warm Heart 81/872 52/860 32.8 % 1.58 [ 1.11, 2.25 ]
Yau A cold A 0/20 1/21 0.3 % 0.14 [ 0.00, 7.16 ]
Yau A cold int. A 3/22 1/21 1.0 % 2.79 [ 0.37, 21.37 ]
Yau A cold R 0/22 3/22 0.8 % 0.12 [ 0.01, 1.25 ]
Yau B 3/26 0/27 0.8 % 8.33 [ 0.83, 83.80 ]
Total (95% CI) 1874 1837 100.0 % 1.21 [ 0.99, 1.48 ]
Total events: 237 (Treatment), 196 (Control)
Heterogeneity: Chi2 = 15.45, df = 11 (P = 0.16); I2 =29%
Test for overall effect: Z = 1.86 (P = 0.063)
Test for subgroup differences: Not applicable
0.1 0.2 0.5 1 2 5 10
Favours treatment Favours control
29Hypothermia to reduce neurological damage following coronary artery bypass surgery (Review)
Copyright © 2013 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.
Analysis 1.5. Comparison 1 Hypothermia versus normothermia, Outcome 5 Intra-aortic balloon pump use
(IABP).
Review: Hypothermia to reduce neurological damage following coronary artery bypass surgery
Comparison: 1 Hypothermia versus normothermia
Outcome: 5 Intra-aortic balloon pump use (IABP)
Study or subgroup Treatment Control
Peto
Odds Ratio Weight
Peto
Odds Ratio
n/N n/N Peto,Fixed,95% CI Peto,Fixed,95% CI
Birdi cold 3/100 4/100 8.1 % 0.74 [ 0.17, 3.35 ]
Engleman cold 1/100 3/98 4.7 % 0.35 [ 0.05, 2.56 ]
Hayashida cold A 0/12 1/12 1.2 % 0.14 [ 0.00, 6.82 ]
Hayashida cold R 0/12 0/12 Not estimable
Lajos 1/54 1/54 2.4 % 1.00 [ 0.06, 16.20 ]
Martin (Emory) 10/508 7/493 19.9 % 1.39 [ 0.53, 3.62 ]
Pelletier 3/100 5/100 9.2 % 0.60 [ 0.15, 2.44 ]
Rashid A 3/144 4/137 8.1 % 0.71 [ 0.16, 3.17 ]
Warm Heart 14/872 21/860 40.8 % 0.66 [ 0.34, 1.28 ]
Yau A cold A 0/20 1/21 1.2 % 0.14 [ 0.00, 7.16 ]
Yau A cold int. A 0/22 1/21 1.2 % 0.13 [ 0.00, 6.51 ]
Yau A cold R 0/22 3/22 3.4 % 0.12 [ 0.01, 1.25 ]
Yau B 0/26 0/27 Not estimable
Total (95% CI) 1992 1957 100.0 % 0.67 [ 0.44, 1.03 ]
Total events: 35 (Treatment), 51 (Control)
Heterogeneity: Chi2 = 6.73, df = 10 (P = 0.75); I2 =0.0%
Test for overall effect: Z = 1.82 (P = 0.069)
Test for subgroup differences: Not applicable
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Analysis 1.6. Comparison 1 Hypothermia versus normothermia, Outcome 6 Pooled “bad” outcomes
(perioperative death, stroke, MI, LOS, IABP).
Review: Hypothermia to reduce neurological damage following coronary artery bypass surgery
Comparison: 1 Hypothermia versus normothermia
Outcome: 6 Pooled ”bad” outcomes (perioperative death, stroke, MI, LOS, IABP)
Study or subgroup Treatment Control
Peto
Odds Ratio Weight
Peto
Odds Ratio
n/N n/N Peto,Fixed,95% CI Peto,Fixed,95% CI
Birdi cold 8/100 8/100 2.2 % 1.00 [ 0.36, 2.77 ]
Cook 0/30 0/30 Not estimable
Engleman cold 31/100 28/100 6.1 % 1.15 [ 0.63, 2.12 ]
Hayashida cold A 0/12 2/12 0.3 % 0.12 [ 0.01, 2.10 ]
Hayashida cold R 0/12 1/12 0.1 % 0.14 [ 0.00, 6.82 ]
Lajos 1/54 7/54 1.1 % 0.20 [ 0.05, 0.84 ]
Landymore 3/20 6/20 1.0 % 0.43 [ 0.10, 1.87 ]
Martin (Emory) 101/508 111/493 24.3 % 0.85 [ 0.63, 1.16 ]
Pelletier 33/100 26/100 6.1 % 1.40 [ 0.76, 2.56 ]
Plourde 0/29 1/33 0.1 % 0.15 [ 0.00, 7.76 ]
Rashid A 46/144 38/137 8.6 % 1.22 [ 0.73, 2.03 ]
Rashid B 4/50 7/58 1.4 % 0.64 [ 0.19, 2.23 ]
Regragui cold 1/31 0/29 0.1 % 6.93 [ 0.14, 349.88 ]
Tonz 1/16 2/14 0.4 % 0.42 [ 0.04, 4.43 ]
Warm Heart 223/872 184/860 45.3 % 1.26 [ 1.01, 1.58 ]
Yau A cold A 1/20 2/21 0.4 % 0.52 [ 0.05, 5.32 ]
Yau A cold int. A 6/22 2/21 1.0 % 3.14 [ 0.69, 14.34 ]
Yau A cold R 0/22 6/22 0.8 % 0.10 [ 0.02, 0.57 ]
Yau B 4/26 1/27 0.7 % 3.82 [ 0.62, 23.72 ]
Total (95% CI) 2168 2143 100.0 % 1.07 [ 0.92, 1.24 ]
Total events: 463 (Treatment), 432 (Control)
Heterogeneity: Chi2 = 29.74, df = 17 (P = 0.03); I2 =43%
Test for overall effect: Z = 0.90 (P = 0.37)
Test for subgroup differences: Not applicable
0.1 0.2 0.5 1 2 5 10
Favours treatment Favours control
31Hypothermia to reduce neurological damage following coronary artery bypass surgery (Review)
Copyright © 2013 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.
Analysis 1.7. Comparison 1 Hypothermia versus normothermia, Outcome 7 Early cognitive function tests.
Review: Hypothermia to reduce neurological damage following coronary artery bypass surgery
Comparison: 1 Hypothermia versus normothermia
Outcome: 7 Early cognitive function tests
Study or subgroup Treatment Control
Mean
Difference Weight
Mean
Difference
N Mean(SD) N Mean(SD) IV,Fixed,95% CI IV,Fixed,95% CI
1 Intellectual IQ function - WAIS RDS
McLean (Warm Heart) 77 5.7 (9.5) 78 6.6 (11.1) 10.7 % -0.90 [ -4.15, 2.35 ]
Mora (Emory) 43 6 (12) 45 6 (12.9) 4.2 % 0.0 [ -5.20, 5.20 ]
Plourde 24 1.2 (8.3) 30 3.2 (11.4) 4.1 % -2.00 [ -7.26, 3.26 ]
Subtotal (95% CI) 144 153 19.0 % -0.94 [ -3.38, 1.50 ]
Heterogeneity: Chi2 = 0.28, df = 2 (P = 0.87); I2 =0.0%
Test for overall effect: Z = 0.75 (P = 0.45)
2 Intellectual IQ function - digit span
Mora (Emory) 47 0 (3.9) 45 1 (3.32) 51.8 % -1.00 [ -2.48, 0.48 ]
Plourde 24 0 (4.67) 30 -0.2 (4.85) 17.4 % 0.20 [ -2.35, 2.75 ]
Subtotal (95% CI) 71 75 69.2 % -0.70 [ -1.98, 0.58 ]
Heterogeneity: Chi2 = 0.64, df = 1 (P = 0.42); I2 =0.0%
Test for overall effect: Z = 1.07 (P = 0.28)
3 Memory - Buschke consistent longterm retrieval
Heyer 40 13.9 (23.8) 46 14.2 (27) 1.0 % -0.30 [ -11.04, 10.44 ]
McLean (Warm Heart) 77 -9.1 (34.6) 78 -7.9 (37.6) 0.9 % -1.20 [ -12.57, 10.17 ]
Subtotal (95% CI) 117 124 1.9 % -0.72 [ -8.53, 7.08 ]
Heterogeneity: Chi2 = 0.01, df = 1 (P = 0.91); I2 =0.0%
Test for overall effect: Z = 0.18 (P = 0.86)
4 Motor skill / dexterity - Trails A
Heyer 40 0 (18.8) 46 -1.3 (14.6) 2.2 % 1.30 [ -5.89, 8.49 ]
McLean (Warm Heart) 77 4.1 (15.5) 78 1.4 (13.65) 5.3 % 2.70 [ -1.90, 7.30 ]
Subtotal (95% CI) 117 124 7.5 % 2.29 [ -1.58, 6.17 ]
Heterogeneity: Chi2 = 0.10, df = 1 (P = 0.75); I2 =0.0%
Test for overall effect: Z = 1.16 (P = 0.25)
5 Motor skill / dexterity - Grooved Pegboard
Heyer 40 10 (39.4) 46 4.7 (29.2) 0.5 % 5.30 [ -9.54, 20.14 ]
McLean (Warm Heart) 77 30.3 (45.05) 78 23.3 (35.5) 0.7 % 7.00 [ -5.78, 19.78 ]
Mora (Emory) 41 14 (44.6) 44 24 (55.4) 0.2 % -10.00 [ -31.31, 11.31 ]
Subtotal (95% CI) 158 168 1.5 % 3.49 [ -5.33, 12.31 ]
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(. . . Continued)
Study or subgroup Treatment Control
Mean
Difference Weight
Mean
Difference
N Mean(SD) N Mean(SD) IV,Fixed,95% CI IV,Fixed,95% CI
Heterogeneity: Chi2 = 1.89, df = 2 (P = 0.39); I2 =0.0%
Test for overall effect: Z = 0.78 (P = 0.44)
6 Executive function - Trails B
Heyer 40 9.8 (61.1) 46 17.7 (62.5) 0.2 % -7.90 [ -34.07, 18.27 ]
McLean (Warm Heart) 77 23.7 (48.1) 78 17.8 (42.2) 0.6 % 5.90 [ -8.35, 20.15 ]
Plourde 24 -7 (36.9) 30 -8 (40.3) 0.3 % 1.00 [ -19.64, 21.64 ]
Subtotal (95% CI) 141 154 1.0 % 2.27 [ -8.43, 12.98 ]
Heterogeneity: Chi2 = 0.84, df = 2 (P = 0.66); I2 =0.0%
Test for overall effect: Z = 0.42 (P = 0.68)
Total (95% CI) 748 798 100.0 % -0.43 [ -1.49, 0.63 ]
Heterogeneity: Chi2 = 7.01, df = 14 (P = 0.93); I2 =0.0%
Test for overall effect: Z = 0.79 (P = 0.43)
Test for subgroup differences: Chi2 = 3.24, df = 5 (P = 0.66), I2 =0.0%
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Analysis 1.8. Comparison 1 Hypothermia versus normothermia, Outcome 8 Late cognitive function tests.
Review: Hypothermia to reduce neurological damage following coronary artery bypass surgery
Comparison: 1 Hypothermia versus normothermia
Outcome: 8 Late cognitive function tests
Study or subgroup Treatment Control
Mean
Difference Weight
Mean
Difference
N Mean(SD) N Mean(SD) IV,Fixed,95% CI IV,Fixed,95% CI
1 Intellectual IQ function - WAIS RDS
McLean (Warm Heart) 77 -4.2 (10) 78 -4.5 (11.6) 5.1 % 0.30 [ -3.11, 3.71 ]
Mora (Emory) 37 -5 (11.7) 45 -4 (13.5) 2.0 % -1.00 [ -6.46, 4.46 ]
Regragui cold 31 -1.5 (4) 29 -1 (5.6) 9.7 % -0.50 [ -2.98, 1.98 ]
Subtotal (95% CI) 145 152 16.9 % -0.32 [ -2.20, 1.57 ]
Heterogeneity: Chi2 = 0.21, df = 2 (P = 0.90); I2 =0.0%
Test for overall effect: Z = 0.33 (P = 0.74)
2 Intellectual IQ function - digit span
Mora (Emory) 39 -2 (4.27) 45 -1 (3.8) 19.7 % -1.00 [ -2.74, 0.74 ]
Regragui cold 31 -0.2 (2.9) 29 -0.8 (3) 26.7 % 0.60 [ -0.89, 2.09 ]
Subtotal (95% CI) 70 74 46.4 % -0.08 [ -1.21, 1.05 ]
Heterogeneity: Chi2 = 1.87, df = 1 (P = 0.17); I2 =46%
Test for overall effect: Z = 0.14 (P = 0.89)
3 Memory - WMS verbal paired associates / associated learning
Mora (Emory) 39 0 (3.7) 45 0 (3.41) 25.5 % 0.0 [ -1.53, 1.53 ]
Regragui cold 25 0.2 (3.9) 24 1.4 (4.6) 10.4 % -1.20 [ -3.59, 1.19 ]
Subtotal (95% CI) 64 69 35.9 % -0.35 [ -1.64, 0.94 ]
Heterogeneity: Chi2 = 0.69, df = 1 (P = 0.41); I2 =0.0%
Test for overall effect: Z = 0.53 (P = 0.60)
4 Motor skill / dexterity - Grooved Pegboard
McLean (Warm Heart) 77 -13.6 (33.3) 78 -12.5 (28.6) 0.6 % -1.10 [ -10.88, 8.68 ]
Mora (Emory) 38 -11 (41.8) 44 -9 (47.9) 0.2 % -2.00 [ -21.42, 17.42 ]
Subtotal (95% CI) 115 122 0.8 % -1.28 [ -10.01, 7.45 ]
Heterogeneity: Chi2 = 0.01, df = 1 (P = 0.94); I2 =0.0%
Test for overall effect: Z = 0.29 (P = 0.77)
Total (95% CI) 394 417 100.0 % -0.23 [ -1.00, 0.55 ]
Heterogeneity: Chi2 = 2.93, df = 8 (P = 0.94); I2 =0.0%
Test for overall effect: Z = 0.57 (P = 0.57)
Test for subgroup differences: Chi2 = 0.16, df = 3 (P = 0.98), I2 =0.0%
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Analysis 2.1. Comparison 2 Hypothermia versus tepid temperature or mild hypothermia, Outcome 1 Non
fatal stroke.
Review: Hypothermia to reduce neurological damage following coronary artery bypass surgery
Comparison: 2 Hypothermia versus tepid temperature or mild hypothermia
Outcome: 1 Non fatal stroke
Study or subgroup Treatment Control
Peto
Odds Ratio Weight
Peto
Odds Ratio
n/N n/N Peto,Fixed,95% CI Peto,Fixed,95% CI
Birdi tepid 0/100 1/100 7.4 % 0.14 [ 0.00, 6.82 ]
Engleman tepid 6/100 3/93 63.5 % 1.86 [ 0.49, 7.07 ]
Fiore 1/27 1/25 14.4 % 0.92 [ 0.06, 15.22 ]
Hayashida tepid A 0/12 1/12 7.4 % 0.14 [ 0.00, 6.82 ]
Hayashida tepid R 0/12 1/12 7.4 % 0.14 [ 0.00, 6.82 ]
Total (95% CI) 251 242 100.0 % 0.94 [ 0.33, 2.73 ]
Total events: 7 (Treatment), 7 (Control)
Heterogeneity: Chi2 = 3.82, df = 4 (P = 0.43); I2 =0.0%
Test for overall effect: Z = 0.11 (P = 0.91)
Test for subgroup differences: Not applicable
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Analysis 2.2. Comparison 2 Hypothermia versus tepid temperature or mild hypothermia, Outcome 2
Perioperative deaths (not strokes).
Review: Hypothermia to reduce neurological damage following coronary artery bypass surgery
Comparison: 2 Hypothermia versus tepid temperature or mild hypothermia
Outcome: 2 Perioperative deaths (not strokes)
Study or subgroup Treatment Control
Peto
Odds Ratio Weight
Peto
Odds Ratio
n/N n/N Peto,Fixed,95% CI Peto,Fixed,95% CI
Birdi tepid 2/100 0/100 33.4 % 7.46 [ 0.46, 120.17 ]
Engleman tepid 1/100 2/93 49.8 % 0.47 [ 0.05, 4.61 ]
Regragui tepid 1/31 0/36 16.7 % 8.68 [ 0.17, 442.38 ]
Total (95% CI) 231 229 100.0 % 1.94 [ 0.39, 9.66 ]
Total events: 4 (Treatment), 2 (Control)
Heterogeneity: Chi2 = 2.94, df = 2 (P = 0.23); I2 =32%
Test for overall effect: Z = 0.81 (P = 0.42)
Test for subgroup differences: Not applicable
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Analysis 2.3. Comparison 2 Hypothermia versus tepid temperature or mild hypothermia, Outcome 3 Non
fatal MI.
Review: Hypothermia to reduce neurological damage following coronary artery bypass surgery
Comparison: 2 Hypothermia versus tepid temperature or mild hypothermia
Outcome: 3 Non fatal MI
Study or subgroup Treatment Control
Peto
Odds Ratio Weight
Peto
Odds Ratio
n/N n/N Peto,Fixed,95% CI Peto,Fixed,95% CI
Birdi tepid 6/100 8/100 81.4 % 0.74 [ 0.25, 2.18 ]
Engleman tepid 1/100 1/93 12.4 % 0.93 [ 0.06, 15.00 ]
Hayashida tepid A 0/12 0/12 Not estimable
Hayashida tepid R 0/12 1/12 6.2 % 0.14 [ 0.00, 6.82 ]
Total (95% CI) 224 217 100.0 % 0.68 [ 0.26, 1.81 ]
Total events: 7 (Treatment), 10 (Control)
Heterogeneity: Chi2 = 0.72, df = 2 (P = 0.70); I2 =0.0%
Test for overall effect: Z = 0.77 (P = 0.44)
Test for subgroup differences: Not applicable
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Analysis 3.1. Comparison 3 Hypothermia versus normothermia, retrograde delivery of cardioplegia,
Outcome 1 Non fatal stroke.
Review: Hypothermia to reduce neurological damage following coronary artery bypass surgery
Comparison: 3 Hypothermia versus normothermia, retrograde delivery of cardioplegia
Outcome: 1 Non fatal stroke
Study or subgroup Treatment Control
Peto
Odds Ratio Weight
Peto
Odds Ratio
n/N n/N Peto,Fixed,95% CI Peto,Fixed,95% CI
Engleman cold 6/100 4/98 19.6 % 1.49 [ 0.42, 5.30 ]
Hayashida cold R 0/12 1/12 2.1 % 0.14 [ 0.00, 6.82 ]
Lajos 0/54 3/54 6.1 % 0.13 [ 0.01, 1.28 ]
Martin (Emory) 6/508 20/493 52.2 % 0.32 [ 0.15, 0.70 ]
Rashid A 4/144 2/137 12.1 % 1.87 [ 0.37, 9.43 ]
Rashid B 2/50 2/58 8.0 % 1.17 [ 0.16, 8.56 ]
Total (95% CI) 868 852 100.0 % 0.55 [ 0.32, 0.97 ]
Total events: 18 (Treatment), 32 (Control)
Heterogeneity: Chi2 = 8.97, df = 5 (P = 0.11); I2 =44%
Test for overall effect: Z = 2.06 (P = 0.040)
Test for subgroup differences: Not applicable
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Analysis 3.2. Comparison 3 Hypothermia versus normothermia, retrograde delivery of cardioplegia,
Outcome 2 Perioperative deaths (not strokes).
Review: Hypothermia to reduce neurological damage following coronary artery bypass surgery
Comparison: 3 Hypothermia versus normothermia, retrograde delivery of cardioplegia
Outcome: 2 Perioperative deaths (not strokes)
Study or subgroup Treatment Control
Peto
Odds Ratio Weight
Peto
Odds Ratio
n/N n/N Peto,Fixed,95% CI Peto,Fixed,95% CI
Engleman cold 1/100 1/98 9.6 % 0.98 [ 0.06, 15.78 ]
Martin (Emory) 8/508 5/493 61.9 % 1.55 [ 0.52, 4.62 ]
Rashid A 3/144 1/137 19.1 % 2.61 [ 0.36, 18.77 ]
Rashid B 0/50 2/58 9.5 % 0.15 [ 0.01, 2.49 ]
Total (95% CI) 802 786 100.0 % 1.31 [ 0.56, 3.11 ]
Total events: 12 (Treatment), 9 (Control)
Heterogeneity: Chi2 = 2.88, df = 3 (P = 0.41); I2 =0.0%
Test for overall effect: Z = 0.62 (P = 0.53)
Test for subgroup differences: Not applicable
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Analysis 4.1. Comparison 4 Hypothermia versus normothermia, antegrade delivery of cardioplegia,
Outcome 1 Non fatal stroke.
Review: Hypothermia to reduce neurological damage following coronary artery bypass surgery
Comparison: 4 Hypothermia versus normothermia, antegrade delivery of cardioplegia
Outcome: 1 Non fatal stroke
Study or subgroup Treatment Control
Peto
Odds Ratio Weight
Peto
Odds Ratio
n/N n/N Peto,Fixed,95% CI Peto,Fixed,95% CI
Birdi cold 0/100 1/100 3.1 % 0.14 [ 0.00, 6.82 ]
Pelletier 2/100 1/100 9.1 % 1.96 [ 0.20, 19.07 ]
Plourde 0/29 1/33 3.1 % 0.15 [ 0.00, 7.76 ]
Warm Heart 13/872 14/860 81.7 % 0.91 [ 0.43, 1.96 ]
Yau A cold int. A 1/22 0/21 3.1 % 7.06 [ 0.14, 356.21 ]
Total (95% CI) 1123 1114 100.0 % 0.93 [ 0.47, 1.85 ]
Total events: 16 (Treatment), 17 (Control)
Heterogeneity: Chi2 = 3.18, df = 4 (P = 0.53); I2 =0.0%
Test for overall effect: Z = 0.20 (P = 0.84)
Test for subgroup differences: Not applicable
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Analysis 4.2. Comparison 4 Hypothermia versus normothermia, antegrade delivery of cardioplegia,
Outcome 2 Perioperative deaths (not strokes).
Review: Hypothermia to reduce neurological damage following coronary artery bypass surgery
Comparison: 4 Hypothermia versus normothermia, antegrade delivery of cardioplegia
Outcome: 2 Perioperative deaths (not strokes)
Study or subgroup Treatment Control
Peto
Odds Ratio Weight
Peto
Odds Ratio
n/N n/N Peto,Fixed,95% CI Peto,Fixed,95% CI
Birdi cold 2/100 1/100 7.6 % 1.96 [ 0.20, 19.07 ]
Pelletier 1/100 1/100 5.1 % 1.00 [ 0.06, 16.10 ]
Plourde 0/29 0/33 Not estimable
Warm Heart 22/872 12/860 84.8 % 1.80 [ 0.91, 3.54 ]
Yau A cold int. A 1/22 0/21 2.5 % 7.06 [ 0.14, 356.21 ]
Total (95% CI) 1123 1114 100.0 % 1.82 [ 0.97, 3.40 ]
Total events: 26 (Treatment), 14 (Control)
Heterogeneity: Chi2 = 0.64, df = 3 (P = 0.89); I2 =0.0%
Test for overall effect: Z = 1.87 (P = 0.061)
Test for subgroup differences: Not applicable
0.1 0.2 0.5 1 2 5 10
Favours treatment Favours control
A D D I T I O N A L T A B L E S
Table 1. Early psychometric test results (within 1 week post op)
Study ID Type of
test
Specific
test
N Inter-
vention
Mean
change
SDDiffer-
ence
N Control Mean
change
SDDiffer-
ence
Interpre-
tation
Mora
(Emory)
1996
Intel-
lectual IQ
function
WAIS re-
vised digit
symbol
43 -6 12 45 -6 12.9 Deteri-
oration in
both
groups
to same ex-
tent
Plourde
1997
WAIS re-
vised digit
symbol
24 -1.2 8.3 30 -3.2 11.4 Deteriora-
tion
greater
in control
group
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Table 1. Early psychometric test results (within 1 week post op) (Continued)
McLean
(Warm
Heart)
1994
WAIS re-
vised digit
symbol
77 -5.7 9.5 78 -6.6 11.1 Deteriora-
tion
greater
in control
group
Mora
(Emory)
1996
WAIS digit
span
47 0 3.9 45 -1.0 3.3 Deteri-
oration in
control
group
Plourde
1997
WAIS digit
span
24 0 4.7 30 0.2 4.85 No deteri-
ora-
tion in ei-
ther group
Plourde
1997
WAIS in-
formation
24 1.4 5.34 30 1.3 6.05 No deteri-
ora-
tion in ei-
ther group
Plourde
1997
WAIS pic-
ture com-
pletion
24 1.1 2.88 30 0.9 3.15 No deteri-
ora-
tion in ei-
ther group
McLean
(Warm
Heart)
1994
Memory WMS vi-
sual repro-
duction
77 0.8 5.9 78 1.5 5.5 No deteri-
ora-
tion in ei-
ther group
Mora
(Emory)
1996
WMS as-
sociated
learning
43 -4.0 3.3 43 -3.0 2.83 Deteriora-
tion
greater in
interven-
tion group
Mora
(Emory)
1996
WMS
mental
control
47 0 1.93 45 -1.0 1.9 Deteri-
oration in
control
group
McLean
(Warm
Heart)
1994
Buschke
total recall
test
77 8 20.3 78 9.2 20.1 No deteri-
ora-
tion in ei-
ther group
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Table 1. Early psychometric test results (within 1 week post op) (Continued)
McLean
(Warm
Heart)
1994
Buschke
CLTR
77 9.1 34.6 78 7.9 37.6 No deteri-
ora-
tion in ei-
ther group
McLean
(Warm
Heart)
1994
Motor skill
/ dexterity
Trails A 77 4.1 15.5 78 1.4 13.65 Deteriora-
tion
greater in
interven-
tion group
Mora
(Emory)
1996
Grooved
pegboard
41 14.0 44.6 44 24.0 55.4 Deteriora-
tion
greater
in control
group
McLean
(Warm
Heart)
1994
Grooved
pegboard
77 30.3 45.1 78 23.3 35.5 Deteriora-
tion
greater in
interven-
tion group
Plourde
1997
Executive
function
Trails B 24 -7.0 36.9 30 -8.0 40.3 Improve-
ment in
both
groups
McLean
(Warm
Heart)
1994
Trails B 77 23.7 48.1 78 17.8 42.2 Deteriora-
tion
greater in
interven-
tion group
Plourde
1997
COWAT 24 2.7 9.2 30 1.5 10.8 Deteri-
oration in
both
groups
Table 2. Late psychometric test results (1-3 months post op)
Study ID Type of
test
Specific
test
N Inter-
vention
Mean
change
SDDiffer-
ence
N Control Mean
Change
SDDiffer-
ence
Interpre-
tation
Mora
(Emory)
1996
Intel-
lectual IQ
function
WAIS re-
vised digit
symbol
37 5 11.7 45 4 13.5 Improve-
ment in
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Table 2. Late psychometric test results (1-3 months post op) (Continued)
both
groups
Regragui -
cold 1996
WAIS re-
vised digit
symbol
31 1.5 4 29 1 5.6 Improve-
ment in
both
groups
McLean
(Warm
Heart)
1994
WAIS re-
vised digit
symbol
77 4.2 10 78 4.5 11.6 Improve-
ment in
both
groups
Mora
(Emory)
1996
WAIS digit
span
39 2 4.3 45 1 3.8 Improve-
ment in
both
groups
Regragui -
cold 1996
WAIS digit
span
31 0.2 2.9 29 0.8 3 Slight im-
prove-
ment both
groups
Regragui -
cold 1996
WAIS pic-
ture ar-
rangement
31 0.2 5.6 28 -1.4 5.2 Deteri-
oration in
control
group
Regragui -
cold 1996
WAIS
block de-
sign
31 -0.5 5.7 29 -1.0 7.1 Deteriora-
tion
greater
in control
group
Regragui -
cold 1996
WAIS ob-
ject assem-
bly
31 0.5 3.9 29 -0.2 5.6 No
real change
in either
group
McLean
(Warm
Heart)
1994
Memory WMS vi-
sual repro-
duction
77 2.2 5.45 78 1.8 5.5 Improve-
ment in
both
groups
Regragui -
cold 1996
WMS vi-
sual paired
associates
23 1.5 4.7 21 -0.1 3.8 Slight im-
prove-
ment in in-
tervention
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Table 2. Late psychometric test results (1-3 months post op) (Continued)
group
Regragui -
cold 1996
WMS ver-
bal paired
associates
25 -0.2 3.9 24 -1.4 4.6 Deteriora-
tion
greater
in control
group
Mora
(Emory)
1996
WMS as-
soci-
ated learn-
ing (same
test as ver-
bal paired
associates)
39 0 3.7 45 0 3.4 No change
in either
group
Mora
(Emory)
1996
WMS
mental
control
39 1 1.85 45 0 1.9 Slight im-
provement
interven-
tion group
McLean
(Warm
Heart)
1994
Buschke
total recall
test
77 8.4 17.7 78 8.2 19.5 Improve-
ment in
both
groups
McLean
(Warm
Heart)
1994
Buschke
CLTR
77 10.3 33.9 78 11.6 35.3 Improve-
ment in
both
groups
McLean
(Warm
Heart)
1994
Motor skill
/ dexterity
Trails A 77 -1.6 11.7 78 -1.8 13.2 Improve-
ment in
both
groups
Mora
(Emory)
1996
Grooved
pegboard
38 -11 41.8 44 -9.0 47.9 Improve-
ment in
both
groups
McLean
(Warm
Heart)
1994
Grooved
pegboard
77 -13.6 33.3 78 -12.5 28.6 Improve-
ment in
both
groups
McLean
(Warm
Heart)
Executive
function
Trails B 77 -10.2 32.9 78 -8.8 33.8 Improve-
ment in
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Table 2. Late psychometric test results (1-3 months post op) (Continued)
1994 both
groups
Table 3. Neurological examination results in hypothermia vs normothermia
Study ID Investigation(s) Results
Engleman cold Mathew Scale measured at baseline, 3-4 days
post op, and I month post op
Deterioration seen in both groups to a similar
extent 3-4 days post op (mean change -4.9 and
4.6 respectively for I and C groups), which is
improved but not resolved at 1 month (mean
change from baseline -1.3 for both groups)
Kadoi 1999 (unpublished data) Mini Mental Status score measured at baseline
and 7 days post op
Deterioration as shown by a decrease in score
was seen in both groups post operatively, with
greater deficit seen in the intervention group
(mean change in score -6 and -4 respectively
for I and C groups)
Martin 1994 (EMORY) Neurological examination 3 days or less post
op. Looked for global confusion or incoher-
ence suggestive of diffuse encephalopathy
Diffuse encephalopathy seen in 0.2% of pa-
tients in the hypothermic group, and 0.4% of
patients in the normothermic group
Mora 1996 (substudy of EMORY) Neurologic assessment included an evaluation
of mental status, motor and sensory function,
hand coordination, deep tendon and primitive
reflexes, at baseline and post operatively before
discharge. Perioperative neurological deficits
were diagnosed by any of the following: altered
level of consciousness or confusion, impaired
speech, visual disturbances, new or worsened
motor or sensory deficits
Perioperative central neurologic deficits were
found in 6/68 patients in the normothermic
group, none in the hypothermic group
Regragui 1996 Full neurologic examination on day 4 post op A positive grasp reflex, and positive Babinski
reflex were elicited in 4/60 patients post oper-
atively (2 in each comparison group)
Table 4. Early and late psychometric test results - moderate vs mild hypothermia
Study ID Type of
test
Specific
test
N Inter-
vention
Mean
Change
SDDiffer-
ence
N Control Mean
Change
SDDiffer-
ence
Interpre-
tation
EARLY
TESTS (1
week post
op)
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Table 4. Early and late psychometric test results - moderate vs mild hypothermia (Continued)
Heyer
1997
Memory Buschke
CLTR
40 -13.9 23.8 46 -14.2 27 Deteri-
oration in
both
groups to
similar ex-
tent
Heyer
1997
Buschke
LTR
40 -21.3 24 46 -21.5 28.5 Deteri-
oration in
both
groups to
similar ex-
tent
Heyer
1997
Motor skill
/ dexterity
Trails A 40 0 18.8 46 -1.3 14.6 Slight im-
provement
in control
group
Heyer
1997
(dominant
hand)
Grooved
pegboard
40 10.0 39.4 46 4.7 29.2 Deteriora-
tion
greater in
interven-
tion group
Heyer
1997
(non-
dominant
hand)
Grooved
pegboard
40 17.1 62.7 46 10.1 34.1 Deteriora-
tion
greater in
interven-
tion group
Heyer
1997
(dominant
hand)
Repetitive
tapping
40 -1.2 9.6 46 -2.9 10.3 Improve-
ment in
both
groups
Heyer
1997
(non-
dominant
hand)
Repetitive
tapping
40 -2.2 7.7 46 -0.9 9.9 Improve-
ment in
both
groups
Heyer
1997
Executive
function
Trails B 40 9.8 61.1 46 17.7 62.5 Deteriora-
tion
greater
in control
group
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Table 4. Early and late psychometric test results - moderate vs mild hypothermia (Continued)
LATE
TESTS (6
weeks post
op)
Regragui -
tepid 1996
Intel-
lectual IQ
function
WAIS re-
vised digit
symbol
31 1.5 4 36 3.4 5.1 Improve-
ment in
both
groups
Regragui -
tepid 1996
WAIS digit
span
31 0.2 2.9 35 0.11 2.7 Very slight
improve-
ment both
groups
Regragui -
tepid 1996
WAIS pic-
ture ar-
rangement
31 0.2 5.6 35 -1.2 4.0 Deteri-
oration in
control
group
Regragui -
tepid 1996
WAIS
block de-
sign
31 -0.5 5.7 35 1.6 5.9 Slight de-
teriora-
tion in the
interven-
tion group.
Regragui -
tepid 1996
WAIS ob-
ject assem-
bly
31 0.5 3.9 36 1.5 4.6 Slight im-
provement
greater
in control
group
Regragui -
tepid 1996
Memory WMS vi-
sual paired
associates
23 1.5 4.7 28 -0.9 4.6 Slight im-
prove-
ment in in-
tervention
group
Regragui -
tepid 1996
WMS ver-
bal paired
associates
25 -0.2 3.9 31 -0.4 3.7 Very slight
deteri-
oration in
both
groups
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Table 5. Neurological examination results in moderate vs mild hypothermia
Study ID Investigation(s) Results
Engleman tepid Mathew Scale measured at baseline, 3-4 days post op,
and I month post op
Deterioration in scores to a similar extent in both
groups (mean change in score -4.9 in the hypothermic
group, -4.6 in the tepid group), this is improved but
not resolved at 1 month (mean change from baseline
-1.3 and -1.8 respectively in the I and C groups)
Regragui 1996 tepid Full neurologic examination on day 4 post op A positive grasp reflex elicited in 3/67 patients (2 in
the hypothermic group, 1 in the tepid group), and a
positive Babinski reflex elicited in 6/67 patients (2 in
the hypothermic group, and 4 in the tepid group)
Heyer 1997 Mini Mental Status score measured at baseline and 6
days post op
No significant change in score in either group.
Heyer 1997 Neurological examination including evaluation of cra-
nial nerves and motor, sensory and cerebellar systems,
gait, station, deep tendon and primitive reflexes, mea-
sured at baseline and post operatively before hospital
discharge
Subtle deficits were detected by neurologic examina-
tion in 35% of patients in the hypothermic group,
and 27% of patients in the normothermic group
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